Patents by Inventor Evan Snape

Evan Snape has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20080090905
    Abstract: A cinchonidine salt, an (R)-(+)-1-(1-naphthyl)ethylamine salt and a (S)-(?)-1-(2-naphthyl)ethylamine salt of (?)-2-{[2-(4-hydroxyphenyl)ethyl]thio}-3-[4-(2-{4-[(methylsulfonyl)oxy]phenoxy}ethyl)phenyl]propanoic acid, processes for their preparation, their use in treating clinical conditions including lipid disorders (dyslipidemias) whether or not associated with insulin resistance and other manifestations of the metabolic syndrome, and pharmaceutical compositions containing them.
    Type: Application
    Filed: December 14, 2005
    Publication date: April 17, 2008
    Inventor: Evan Snape
  • Patent number: 7012145
    Abstract: Process for preparing 3-[(4S)-5-oxo-2-(trifluoromethyl)-1,4,5,6,7,8-hexahydroquinolin-4-yl]benzonitrile, pharmaceutical compositions containing the compound and methods of treatment using the same.
    Type: Grant
    Filed: January 23, 2003
    Date of Patent: March 14, 2006
    Assignee: Astrazeneca AB
    Inventors: Andrew Jones, Jonathan Moseley, Ian Patel, Evan Snape, Maureen Young
  • Publication number: 20050080104
    Abstract: Process for preparing 3-[(4S)-5-oxo-2-(trifluoromethyl)-1,4,5,6,7,8-hexahydroquinolin-4-yl]benzonitrile, pharmaceutical compositions containing the compound and methods of treatment using the same.
    Type: Application
    Filed: January 23, 2003
    Publication date: April 14, 2005
    Inventors: Andrew Jones, Jonathan Moseley, Ian Patel, Evan Snape, Maureen Young